Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer

Radiation: Drug target found for radioresistance Drugs that block the androgen receptor (AR) protein can help make radiation-resistant breast tumors susceptible to ionizing therapy. Corey Speers from the University of Michigan, Ann Arbor, USA, and colleagues characterized the radiation sensitivity o...

Full description

Bibliographic Details
Main Authors: Corey Speers, Shuang G. Zhao, Ben Chandler, Meilan Liu, Kari Wilder-Romans, Eric Olsen, Shyam Nyati, Cassandra Ritter, Prasanna G. Alluri, Vishal Kothari, Daniel F. Hayes, Theodore S. Lawrence, Daniel E. Spratt, Daniel R. Wahl, Lori J. Pierce, Felix Y. Feng
Format: Article
Language:English
Published: Nature Publishing Group 2017-08-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-017-0038-2

Internet

https://doi.org/10.1038/s41523-017-0038-2

Similar Items